Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration.
Int J Cardiol
; 338: 150-151, 2021 09 01.
Article
in En
| MEDLINE
| ID: mdl-34139230
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Arrhythmogenic Right Ventricular Dysplasia
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Int J Cardiol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos